Your Patient Needs Dronabinol — How Can You Help Them Find It?

You've written the prescription. The clinical rationale is clear. Your patient needs Dronabinol for HIV/AIDS-related anorexia or refractory chemotherapy-induced nausea and vomiting. And then the phone call comes: "My pharmacy doesn't have it."

This scenario has become increasingly common. While Dronabinol is not in an official FDA-designated shortage, many patients face real barriers to filling their prescriptions. As a prescriber, there are concrete steps you can take to reduce these barriers and keep your patients on therapy.

Current Dronabinol Availability Landscape

Understanding the supply picture helps you anticipate problems and counsel patients effectively:

• Formulations available: Only capsules (2.5 mg, 5 mg, 10 mg) are currently on the market. Syndros oral solution has been discontinued
• Manufacturers: Brand Marinol (AbbVie) plus generics from Camber Pharmaceuticals, Par Pharmaceutical, and a limited number of other producers
• DEA classification: Schedule III (capsules), which allows refills but subjects manufacturing to DEA quotas
• Pharmacy stocking: Many chain pharmacies do not routinely stock Dronabinol, requiring special orders with 2-5 day lead times

For a detailed timeline of recent supply disruptions, see our Dronabinol shortage briefing for providers.

Why Patients Can't Find Dronabinol

When your patient calls to say they can't fill their prescription, the issue usually falls into one of these categories:

1. Pharmacy Doesn't Stock It

The most common scenario. Large chain pharmacies make centralized stocking decisions based on prescription volume and margin. Dronabinol — a controlled substance with moderate volume — often doesn't make the cut for standard inventory. The pharmacy can order it, but the patient may not know that or may not want to wait.

2. Wholesaler Supply Disruption

Even when a pharmacy orders Dronabinol, their wholesaler may not have it in stock. With only a few generic manufacturers, any production issue can create downstream delays.

3. Insurance and Prior Authorization Delays

Many insurance plans require prior authorization for Dronabinol. If the PA hasn't been submitted or approved before the patient arrives at the pharmacy, the prescription gets held up — even if the pharmacy has it in stock.

4. Cost Barrier

For uninsured patients, generic Dronabinol can cost $250-$350+ for a 30-day supply at retail. Even with discount coupons ($68-$83), this may be prohibitive. Some patients simply can't afford to fill the prescription they received.

What Providers Can Do: 5 Practical Steps

Step 1: Verify Pharmacy Stock Before Prescribing

Use Medfinder for Providers to check which pharmacies near your patient have Dronabinol in stock. You can do this from your office during the appointment, directing the prescription to a pharmacy you know has it. This single step eliminates the most common failure point.

Step 2: Submit Prior Authorization Proactively

Don't wait for the pharmacy to trigger the PA process. If you know the patient's plan requires prior authorization, submit it when you write the prescription — or even before. Key documentation to include:

• Diagnosis (ICD-10 codes: R63.0 for anorexia, R11.0/R11.2 for nausea/vomiting)
• Clinical rationale and failed alternatives for CINV indication
• Duration of treatment need

Electronic prior authorization (ePA) through your EHR can streamline this significantly.

Step 3: Prescribe Generic Dronabinol Explicitly

Specify generic Dronabinol on the prescription unless there's a clinical reason for brand Marinol. Generic is more widely stocked, significantly cheaper, and more likely to be covered without additional PA requirements. Avoid writing for Marinol by brand unless necessary — some pharmacies may not stock brand but do carry generic.

Step 4: Recommend Specific Pharmacies to Patients

Maintain a short list of pharmacies in your area that reliably stock Dronabinol. This might include:

• Independent pharmacies that serve your patient population
• Specialty pharmacies focused on oncology or HIV care
• Hospital outpatient pharmacies

Share this list with patients at the time of prescribing so they don't waste time at pharmacies that won't have their medication.

Step 5: Provide Cost-Saving Resources

For patients facing cost barriers, share these resources during the visit:

• GoodRx / SingleCare coupons: Can reduce generic Dronabinol to ~$68-$83 for 60 capsules
• Prescription Hope: ~$50-$70/month for qualifying patients
• State ADAPs: For HIV patients, the AIDS Drug Assistance Program may cover Dronabinol
• NeedyMeds / RxAssist: Patient assistance program databases

Direct patients to our Dronabinol savings guide for detailed instructions.

Clinical Alternatives When Dronabinol Is Unavailable

When Dronabinol cannot be obtained in a clinically acceptable timeframe, consider these evidence-based alternatives:

For Chemotherapy-Induced Nausea and Vomiting

• Nabilone (Cesamet): Synthetic cannabinoid, Schedule II. More potent and longer-acting than Dronabinol. 1-2 mg BID. Note: also a controlled substance with potential availability challenges
• Ondansetron (Zofran): 5-HT3 antagonist, first-line therapy. Widely available, not controlled. Good option if patient hasn't failed this class
• Olanzapine: Emerging evidence for CINV prevention, especially with highly emetogenic regimens. NCCN-recommended as part of multi-drug antiemetic regimens
• Granisetron (Kytril) / Palonosetron (Aloxi): Alternative 5-HT3 antagonists

For HIV/AIDS-Related Anorexia and Weight Loss

• Megestrol Acetate (Megace): Synthetic progestational agent. FDA-approved for AIDS-related anorexia. Available as oral suspension. Not a controlled substance. Consider VTE risk
• Oxandrolone: Anabolic steroid option for wasting syndrome. Schedule III. Requires monitoring for hepatotoxicity

For a patient-friendly overview of alternatives, refer patients to: Alternatives to Dronabinol.

Workflow Tips for Your Practice

Build a Controlled Substance Availability Checklist

For medications like Dronabinol that have known availability challenges, create a standard workflow:

1. Check Medfinder at time of prescribing
2. Submit PA simultaneously with e-prescribing
3. Provide patient with pharmacy recommendation and cost-saving resources
4. Schedule follow-up confirmation (call or portal message) within 48 hours to verify the patient was able to fill

Designate a Staff Point Person

Having one staff member (MA, nurse, or pharmacy liaison) who manages controlled substance availability issues can dramatically reduce provider time spent on callbacks. This person can:

• Monitor PA approvals
• Call pharmacies to verify stock
• Communicate alternatives to the prescriber when needed

Document Availability Issues in the Chart

When a patient reports Dronabinol availability problems, document it. This creates a record that supports:

• Future PA appeals ("patient unable to obtain prescribed medication")
• Clinical justification for alternative agents
• Practice-level data on drug access challenges

Final Thoughts

Dronabinol access challenges are a solvable problem at the practice level. By verifying stock before prescribing, streamlining prior authorization, maintaining pharmacy relationships, and having a clear alternatives protocol, you can keep patients on appropriate therapy with minimal delays.

Medfinder for Providers is designed to integrate into your prescribing workflow. It takes seconds to check availability and can save hours of callbacks for your team.

For the provider-focused cost savings guide, see: How to Help Patients Save Money on Dronabinol.